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Abstract
 .In this work, we verified that transferrin fluorescently labelled with lissamine rhodamine sulfochloride Tf-LRSC is
internalized in epidermoid A431 carcinoma cells through the specific endocytic pathway of transferrin. The FRAP of this
 .fluorescent marker internalized in the late compartment of transferrin endocytosis LCT was measured in living A431 cells.
These experiments showed the presence of an active intracellular transport of Tf-LRSC which can be interpreted by a
mechanism involving carrier vesicles budding from stationary vacuoles, saltating along microtubules and fusing with other
stationary vacuoles, according to previous video-microscopy observations of a membranous traffic dynamics in these cells,
 . revealed by a gold complex of an Anti-Transferrin Receptor ATR M. De Brabander, R. Nuygens, H. Geerst, C.R.
 . .Hopkins, Cell. Motil. Cystoskel. 9 1988 30 . When the A431 cells were treated with nocodazole or metabolic inhibitors,
there remained a residual FRAP which was ascribed to the spontaneous reactivation of the bleached molecules. According
  . .to a theoretical result obtained in the companion paper P. Wahl, F. Azizi, Biochim. Biophys. Acta 1327 1997 69–74 , we
derived the fractional FRAP characterizing the transport process of Tf-LRSC by subtracting the fractional FRAP of the
nocodazole-treated cells from the fractional FRAP of the non-treated cells. This FRAP of transport was fitted to a formula
derived in that companion paper and based on the mechanism outlined above. From the time constant value determined by
this fit, the number of vesicles which fused with a unit of vacuole surface was calculated to be 0.15 mmy2 sy1. The rate
value of the fusion of vesicles with vacuoles was divided by two in cells treated by AlFy, and increased to 20% in cells4
treated with Brefeldin A. These results correspond to an homotypic fusion process regulated by an heterotrimeric G-protein.
Our work suggests that FRAP can be used to bring information on the transport of membrane components in living
eukaryotic cells. q 1997 Elsevier Science B.V.
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1. Introduction
w xAs mentioned in a companion paper 1 , the video
microscopy observations show that there is an active
0005-2736r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved.
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transport of membranes and of an Antitransferrin
 .Receptor-gold complex ATR-gold between the sta-
tionary vacuoles forming the late compartment of
 . w xtransferrin endocytosis in A431 cells LCT 2 .
We investigated the possibility of using the FRAP
technique for obtaining information on this transport.
Transferrin conjugated to Lissamine Rhodamine
 .Sulfochloride Tf-LRSC can be used as a fluorescent
w xmarker of transferrin endocytosis 3–6 . In the pre-
sent work, we measured the FRAP of Tf-LRSC
internalized in the late endosomal system of A431
cells. We found an important FRAP of Tf-LRSC
when the cells were surrounded by their culture
medium. This FRAP was considerably reduced when
the cells were treated with nocodazole or with
metabolic inhibitors. These experimental data were
analysed according to the theory presented in a com-
w xpanion paper 1 .
 y.When we added aluminum fluoride AlF or4
 .Brefelding A BFA to the medium surrounding the
labelled cells, we noticed a change of FRAP consis-
tent with the general action of these compounds on
the homotypic membranous transport in living cells
w x7 .
2. Materials and methods
2.1. Reagents
Human apotransferrin was purchased from Sigma
or Calbiochem. Lissamine Rhodamine Sulfochloride
 .LRSC was obtained from Kodak or Molecular
 .Probe. Sodium azide NaN from Merck and sodium3
 .fluoride NaF from Prolabo. All other proteins and
compounds as well as the culture media were from
Sigma.
2.2. Cell culture
The human epidermoid A431 carcinoma cells were
purchased from the Public Health Laboratory Service
 .Salisbury, U.K. . A431 cells were cultured as mono-
layers in plastic flasks at 378C in a humidified atmo-
sphere with 5% CO in DME Dulbecco’s Modified2
.Eagle’s Medium without phenol red, completed with
Hepes buffer and sodium bicarbonate at a final con-
centration of 10 mM plus 10% of calf serum, 1%
Insulin, 100 mM oxaloacetic acid and 50 mM pyruvic
acid. When islets of cells covered 70% of the culture
flask surface, 2P105 to 4P105 cells were plated on
circular glass coverslips placed in Petri dishes and
subcultured during 2 or 3 days. Viability tests and
mycoplasma controls were regularly performed. Be-
fore FRAP, microfluorimetric measurements and con-
focal microscopy observations, the coverslips with
adherent cells were washed two times with DME and
then incubated in DME at 378C during 60 min in the
 .CO incubator preincubation period .2
2.3. Preparation of diferric transferrin
 .In order to prepare diferric transferrin Tf and Tf
 .labelled with LRSC Tf-LRSC we followed a modi-
fied protocol provided by Dr. A. Dautry-Varsat. 50
mg of apotransferrin were incubated in 0.5 ml of PBS
 .pH 7.4 phosphate buffer 10 mM, NaCl 0.14 M
during 10 min at 378C. A solution of 1.35 mg of
 .ammonium ferric citrate in 0.6 ml PBS pH 7.4 was
slowly added to the apotransferrin solution.
The solution was then incubated for 3 h at room
temperature and shaded from light, dialysed over
night in a cold room against 1 liter of PBS and
dialysed a second time under the same conditions
during 6 h. Tf. was over 90% saturated with iron, as
shown by measuring the ratio of absorbance
w xA rA 8 .465 480
2.4. Preparation of the fluorescent Tf conjugate
10 mg of LRSC was dissolved in a solvent con-
taining 0.4 ml of fresh dioxane and 0.1 ml of dimethyl
formamide. The solution was centrifuged and the
LRSC concentration determined by absorbance mea-
 y1. w xsures at 565 nm es73 000 l M 9 . Tf was
 .dissolved in bicarbonate 1 M pH 9 , to which five
aliquots of a volume containing a weight of LRSC
equal to 5% of the protein weight was slowly added.
The whole process lasted 50 min, at room tempera-
ture in the dark. The reaction was stopped by the
addition of NH Cl at a final concentration of 50 mM.4
The fluorescent protein was purified with a fine
 .G-25 Sephadex column 0.5=20 cm equilibrated
 .with PBS pH 7.4 at 48C. Tf-LRSC was stored in
aliquots of 20 ml at y208C. The average number of
LRSC residues per protein molecule was equal to 3,
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as determined by the absorbance of Tf-LRSC solu-
tion at 570 nm and 280 nm. The purity of Tf-LRSC
was controlled by C thin-layer chromatography18
 .RD18-F254s plates from Merck . The elution sol-
vent was made of nine volumes of acetonitrile and
one volume of water.
2.5. FRAP apparatus
w xWe previously described the FRAP apparatus 10 .
The emission wavelength was 514.5 nm, provided by
 .an Argon ion laser 2016-04 Spectra Physics . For the
experiments we chose an output power of 80 mW
and a bleaching time of 20 ms. The beam was
attenuated 6P103 times during the prebleaching and
the recovery phases. The microscope was equipped
with a neofluar air objective of magnitude 40 and a
numerical aperture NAs0.75, providing a laser beam
Gaussian radius Ws1.8 mm in the observation plane.
The fluorescence beam detected by the photomulti-
plier was limited by the microscope photometer di-
w xaphragm 10 , the optical projection of which in the
object space was S s8 mm. We calculated the laser0
beam persistence length and the optical sectioning
characteristic length by the following expressions
w x11 :
Z snP W 2rl1
1r22Z sS 1qcosa r 4y 1qcosa .  . /e 0
where n is the refractive index of the objective
medium, l the wavelength of the laser beam and
where a is defined as follows:
assiny1 NArn .
Numerical calculations taking the parameters of our
experimental set up into account yield:
Z s20.4 mm1
Z s11.9 mme
Those values are significantly larger than the half
 .thickness of the A431 cells ;7.5 mm . This justi-
 . w xfies the use of Eq. 16 of a companion paper 1 , for
calculating the bleached fluorescence of each marker
species. The interval between two time points was
0.33 s and the total time of exploration of a FRAP
experiment was 200 s.
2.6. Preparation of cells for FRAP measurements
After the preincubation period in DME, as de-
 .scribed above, the coverslips partly about 70%
overlaid with adherent cells were washed two times
at 378C with DME, then incubated 60 min in DME
 .containing 500 nM of Tf-LRSC labelled cells or
 .without Tf-LRSC non-labelled cells for autofluo-
rescence measurements. The cells were then washed
 .and post-incubated during 60 min chase period in
DME without any added compound or in DME con-
taining one or two active compounds 3 mM nocoda-
zole, 5 mM NaFq100 mM AlCl , or 7 or 203
.mgrml of BFA as described later. The coverslips
were then washed four times, put in a Dvorak Cham-
w xber 12 thermostated at 378C and filled with the
post-incubation medium and the whole set was placed
on the microscope stage of the FRAP apparatus. In
some experiments, the cells were washed with PBS
after the preincubation. The incubation with TF-LRSC
was made as above except that PBS replaced DMF.
The post-incubation was carried out in PBS without
any addition, or in PBS containing metabolic in-
 .hibitors 2 mM NaFq20 mM NaN . All the incuba-3
tions and the post-incubations were performed at
378C in a humidified atmosphere with 5% CO .2
2.7. FRAP measures
A single FRAP measurement was performed on a
given cell and was repeated during one hour on
different cells of the same coverslip. Then another
coverslip newly post-incubated was measured. La-
belled and non-labelled cells were alternately mea-
sured. Strong fluctuations of intensity affected each
FRAP curve of a single cell. These curves could not
be analysed by a continuous function. Therefore
curves obtained from a number of labelled cells
submitted to one of the treatments described above
were summed and corrected for the autofluorescence
by subtracting from the sum of curves of labelled
cells a sum of FRAP measured on non-labelled cells
submitted to the same treatment, except that the
incubation medium did not contain any Tf-LRSC. A
multiplicative factor was used to take account of the
difference between the number of cells measured in
each series of experiment, when required.
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The fractional FRAP was then computed by the
w xfollowing relation 13 :
y t s F t yF 0 r F y yF 0 1 .  .  .  .  .  . .  .
 .  .where F - and F t were the corrected fluorescence
sums of the labelled cells during the prebleaching
period and at a time t after bleaching, respectively.
The exponential function defined in a companion
w xpaper 1 was fitted to the experimental fractional
FRAP by the least-squares method. For that purpose
we used a SX386 IBM microcomputer.
2.8. Microfluorimetry
Measurements of the binding of Tf-LRSC to A431
cell surface, of the intracellular accumulation of Tf-
LRSC and of the chase of internalized Tf-LRSC,
were performed by microfluorimetry, with the FRAP
apparatus having its bleaching shutter kept perma-
nently closed. The Photon count was measured dur-
ing one second. The cells were thermostated at 48C in
order to block all physiological processes able to
modify the location of Tf-LRSC. The interrogation
beam power was 33 mW.
2.9. Confocal microscopy
Confocal microscopy studies were performed with
a Bio-Rad MRC-600 microscope controlled by a
computer system. We used a krypton laser and a
block of filters YHS composed of an interference
filter of excitation centered at 568 nm, a dichroic
mirror and a barrier filter which rejected light of
wavelength smaller than 585 nm on the detecting side
of the apparatus.
Cells cultured on a coverslip were preincubated,
incubated and post-incubated under the same condi-
tions as for the FRAP experiments. The cells were
then fixed by immersion during 60 min at 48C in a
newly prepared solution of 1% of p-formaldehyde.
The coverslip bearing the cells was put on a micro-
 .scope slide. A drop of PBSrglycerol 1:1, vrv
 .containing 1% DABCO Sigma, St. Louis, MO, USA
was laid down on the cells that were then covered
with a second coverslip. Both coverslips being sealed
with a mixture of vaseline and lanoline and the
preparation was placed on the microscope stage.
3. Results
3.1. The binding of Tf-LRSC on the surface of the
A431 cells
These measurements were performed with mi-
crofluorimetry as described in Section 2. The cells
subcultured on coverslips were incubated during 90
min at 48C in DME containing various concentrations
of Tf-LRSC. The cells were washed at 48C and their
fluorescence measured at the same temperature. At
48C the endocytosis was inhibited and Tf-LRSC was
bound to the cell surface. These microfluorimetric
measurements were repeated on 100 Tf-LRSC la-
belled cells, then we computed the average of the
fluorescence intensity. The mean autofluorescence
was also determined on non-labelled cells, under the
same conditions. The mean fluorescence of Tf-LRSC
bound to a cell was obtained by the difference be-
tween the mean fluorescence of labelled and non-
labelled cells.
We also determined the fluorescence of A431 cells
incubated in DME containing 1 mM of Tf-LRSC plus
100 mM of Tf-Fe, during 90 min at 48C. The average
fluorescence measured under these conditions was
equal to the average autofluorescence of the cells.
This result shows that the fluorescence of Tf-LRSC
comes exclusively from molecules bound to the Tf
specific binding sites on the A431 plasma membrane.
The variation of the Tf-LRSC fluorescence bound
to the cell surface was plotted as a function of the
Tf-LRSC concentration in the incubation medium
Fig. 1. Binding of Tf-LRSC to the surface of A431 cells. Cells
were incubated 90 min at 48C in DMF containing Tf-LRSC at
various concentrations. The fluoresence was measured by mi-
crofluorimetry.
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Fig. 2.
Fig. 2.
 .Fig. 1 . From this curve, the Tf-LRSC binding to the
Tf-receptors of the plasma membrane appeared to be
saturable. We determined an approximate value of
the dissociation constant K equal to 80 nM. Thisd
value was somewhat higher than the values of the
binding of 125I-Tf-Fe to several cell types in which
w xK varied from 2 nM to 30 nM 13,14 . Labellingd
Tf-Fe with LRSC might cause a decrease in its
affinity for the Tf-receptors.
3.2. Internalization of Tf-LRSC in A431 cells; confo-
cal microscopy
A431 cells were incubated during 60 min at 378C
in DME containing 500 nM of Tf-LRSC and immedi-
ately fixed or post-incubated during 60 min at 378C
in DME and then fixed. The cells were then exam-
Fig. 2.
Fig. 2. Confocal microscopy image of A431 cells having endo-
cyted Tf-LRSC. Cells were incubated in DME containing 500
nM of Tf-LRSC during 60 min at 378C, then post-incubated
 .  .during 60 min at 378C in: 1, top left DME; 2, top right
y  .  .DMEqAlF ; 3, bottom left DMEqBFA; 4, bottom right4
DMEqnocodazole. Finally cells were immersed in a solution of
1% of p-formaldehyde during 60 min at 48C and observed with
the confocal microscope.
ined with the confocal microscope at different cross-
sections. Tf-LRSC fluorescence appeared punctate, a
typical image of fluorescent compounds internalized
in intracellular vacuoles.
By confocal microscopy we also investigated A431
cells treated with compounds known to influence the
morphology and the dynamic properties of membrane
organelles. In these cases, cells were post-incubated
during 60 min in DME containing 5 mM NaFq100
 y.  .mM AlCl AlF or BFA 7 or 20 mgrml or3 4
 .nocodazole 3 mM .
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In all cases the fluorescence was localized in
vacuoles more of less scattered in the cytoplasm. The
vacuoles of AlFy-treated cells were more strongly4
aggregated in the perinuclear area than those of non-
 .treated cells Fig. 2 . The same effect had previously
been observed with NRK cells in which the compart-
ment containing Tf had been labelled by immuno-
w xfluorescence 7 . In cells treated with BFA, a network
 .of fluorescent tubules could be seen Fig. 2 . This
agrees with previous fluorescence microscopy obser-
vations in other cell types and particularly in NRK
w xcells 7 . In cells treated with nocodazole, the fluores-
cent vacuoles were quite dispersed throughout the
cytoplasm. The fluorescent images of cells treated
with AlFy or BFA, then incubated during 60 min at4
378C with AlFyqnocodazole or BFAqnocodazole,4
were similar to those of cells treated with nocodazole
 .alone Fig. 2 . These observations suggest that the
aggregation of vacuoles in AlFy-treated cells as well4
as the tubular structure in BFA-treated cells, required
the presence of microtubules.
3.3. Internalization of Tf-LRSC in A431 cells; mi-
crofluorimetry
The A431 cells were incubated at 378C in DME
with 500 nM of Tf-LRSC and extensively washed at
48C. Some of these cells were then incubated in PBS
containing 50 mgrml of trypsin during 60 min at
48C. The trypsin treatment of the cells did no change
their average fluorescence. This means that the fluo-
rescence of the surface bound Tf-LRSC was negligi-
ble.
We also compared the fluorescence of cells incu-
bated in DME containing 500 nM of Tf-LRSC in
presence and in absence of 50 mM of Tf-Fe at 378C
during 60 min. We found that the average fluores-
cence of cells incubated in presence of Tf-Fe was less
than 12% of the fluorescence measured in cells incu-
bated in absence of the non-labelled protein. This
result meant that over 88% of Tf-LRSC was internal-
ized by means of Tf-receptor.
3.4. Chase of Tf-LRSC internalized in A431 cells
A431 cells were incubated in DME containing 500
nM of Tf-LRSC during 60 min at 378C, extensively
washed at 48C and post-incubated at 378C during
Fig. 3. Kinetics of chase of Tf-LRSC internalized in A431 cells.
 .  .F t rF 0 is the relative fluorescence at the time t of chase.
Fluorescence of Tf-LRSC was measured on cells after the follow-
ing treatments. I, Incubation in DME containing 500 nM of
Tf-LRSC during 60 min at 378C and post-incubation in DME
containing 50 mM of Tf-Fe during various times at 378C. ‘,
Incubation in PBS containing 500 nM of Tf-LRSC during 60 min
at 378C and post-incubation in PBS containing 50 mM of mon-
ensin plus 50 mM of TF-Fe. =, Incubation in PBS containing
500 nM of Tf-LRSC during 40 min plus incubation in the same
medium containing metabolic inhibitions 2 mM of NaFq20
.mM of NaN during 20 min and post-incubation in PBS contain-3
ing the same concentration of inhibitors during 0 or 60 min at
378C.
various time intervals in DME containing 50 mM of
Tf-Fe, in order to facilitate the dissociation of Tf-
w xLRSC from the cell surface receptors 15 . The cells
were then washed with DME and their fluorescence
measured at 48C by microfluorimetry.
The kinetics of Tf-LRSC chase was plotted on Fig.
3. Each point on the curve represented the average
value of two experiments. It can be seen on Fig. 3
that the Tf-LRSC fluorescence rapidly decreased dur-
ing about 10 min of chase, with t s3 min. After1r2
those 10 min of chase, the fluorescence was reduced
to 45% of its initial value. Then the fluorescence
remained equal to 40% of its initial value after 50
min of chase. Even after 120 min of chase in DME
containing 100 mM of Tf-Fe, we could not detect any
significant change of the Tf-LRSC fluorescence of
cells. Similar chase profiles have been measured for
125 w xI-Tf 15–19 .
The rapid decrease of Tf-LRSC fluorescence dur-
ing the first minutes of chase must be ascribed to the
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exocytosis of the internalized Tf-LRSC. It has been
shown by other authors that the iron contained in
ferrotransferrin bound to its receptors dissociates it-
self from the protein at the acid pH of endosomes
w x18,19 . While the apotransferrin remains associated
with its receptors, and the complex is recycled back
to the cell surface where the apotransferrin is released
in the extracellular medium. Thus our microfluori-
metric measurements show that Tf-LRSC has the
same behaviour as Tf. In order to confirm this con-
clusion, we performed the experiments of chase in
presence of metabolic inhibitors or monensin.
Cells were incubated at 378C in PBS containing
500 nM of Tf-LRSC during 40 min, then further
incubated for 20 min in the same medium containing
the following metabolic inhibitors: 2 mM NaFq20
mM NaN . The cells were washed extensively with3
PBS at 48C, then post-incubated in PBS containing
the same concentration of metabolic inhibitors plus
50 mM of Tf-Fe, during 60 min at 378C. The cells
were again extensively washed in PBS at 48C and
their fluorescence measured by microfluorimetry at
the same temperature. The fluorescence intensity did
not decrease during the 60 min period of chase see
.Fig. 3 . This result agreed with the work of Pod-
w xbilewicz and Mellman 20 who showed that Tf exo-
cytosis was blocked by metabolic inhibitors.
We also studied the effect of monensin on Tf-LRSC
exocytosis. Cells were incubated in PBS containing
500 nM of Tf-LRSC at 378C during 60 min, then
post-incubated in PBS with 50 mM of monensin and
50 mM of Tf-Fe during various time intervals. The
cells were then washed and their fluorescence was
measured as described above. As it can be seen on
Fig. 3, the rate of Tf-LRSC exocytosis in monensin-
treated cells was significantly slower than in non-
treated cells. These results agreed with the measure-
ment of 125I-Tf exocytosis by Ciechanover et al.
 . w x1983 19 who showed that monensin neutralizes
the endosome pH and therefore inhibits the formation
of apotransferrin. The ferrotransferrin-receptor com-
plex is then recycled back to the cell surface and
reendocytosed. Therefore monensin induces a de-
crease of the exocytosis rate of 125I-Tf exocytosis.
3.5. FRAP of Tf-LRSC endocytosed in A431 cells
surrounded by their culture medium
FRAP was measured on 173 A431 single cells as
described in Section 2. After having internalized
Tf-LRSC, these cells were post-incubated during 60
min in DME without added compound.
Each FRAP measurement recorded on a single cell
presented strong fluctuations of fluorescence intensity
and there was considerable variation between the
FRAP of different cells. A strong decrease of these
random fluctuations was found in the curve represent-
ing the sum of the 173 individual measurements. This
sum of FRAP curves was corrected for cell autofluo-
rescence as described in Section 2. The resulting
corrected Tf-LRSC FRAP curve was drawn in Fig. 4
and the corresponding fractional fluorescence was
represented in Fig. 5. We reported some avarage
parameters of FRAP in Table 1.
Table 1
Prebleaching fluorescence and bleached fraction of FRAP measures on Tf-LRSC endocyted in A431 cells
  .:  .   .:  .  .Surrounding medium F - "s N F - "s N P %N A N
a  .  .DME 1780" 43 173 241"12 72 44
yb  .  .DMEqAlF 1952" 59 121 313"12 60 554
c  .  .DMEqBFA 1620" 27 149 305"11 34 42
d  .  .DMEqnocodazole 2179"118 75 345"27 35 48
  .:   .:F - , mean prebleaching Tf-LRSC fluorescence per cell, taken over N cells. F - , mean prebleaching autofluorescence. s ,A N
 .standard error of the mean fluorescence. P % , amount in per cent of bleached fluorescence at the end of the bleaching phase of labelled
cells. The mean fluorescences are expressed in number of photoelectrons detected per 0.33 s the interval between two consecutive time
.points in a FRAP record .
a  .Dulbecco’s Modified Eagle’s Medium DME .
bDMEq5 mM NaFq100 mM AlCl .3
cDMEq7 mgrml BFA.
dDMEq3 mM nocodazole.
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Fig. 4. FRAP of Tf-LRSC internalized in A431 cells surrounded
 .  . y  .by the following media: 1 DME; 2 DMEqAlF ; 3 DMEq4
 .BFA; 4 DMEqnocodazole. The meaning of these abreviations
are given in the legend of Table 2.
3.6. FRAP of Tf-LRSC endocytosed in A431 cells
post-incubated with the culture medium containing
nocodazole or metabolic inhibitors
When Tf-LRSC labelled cells were post-incubated
in DME containing 3 mM of nocodazole, the fluctua-
tions affecting the FRAP of a single cell surrounded
by the post-incubation medium were much smaller
than the fluctuations of the FRAP of non-treated
Fig. 5. Fractional FRAP of Tf-LRSC internalized in A431 cells.
These curves were calculated from the curves of Fig. 4 by
 .applying Eq. 1 . The numerical index of each curve refer to the
same media as in Fig. 4.
cells. As before, the FRAP curves of individual cells
were summed and this sum was corrected for the cell
autofluorescence. The resulting corrected FRAP curve
was drawn on Fig. 4 and the corresponding fractional
FRAP on Fig. 5.
If we substituted DME by PBS during the incuba-
tion, the post-incubation and the FRAP measure-
ments, the sum of the FRAP of individual cells did
 .not change data not shown . If in the post-incubation
and measurement media, metabolic inhibitors 2 mM
.NaFq20 mM NaN were added, the sum of the3
FRAP curves of single cells was similar to the sum of
the FRAP of nocodazole-treated cells data not
.shown .
As shown on Fig. 4 and Fig. 5, nocodazole as
.well as metabolic inhibitors bring about an important
decrease of the fluorescence recovery of Tf-LRSC
endocytosed in A431 cells. This result suggests that
an active intracellular Tf-LRSC transport depending
on the energy supply and on the microtubule integrity
of cells contributes to the FRAP of the cells sur-
rounded by their normal culture medium.
There remains, however, in cells treated by noco-
 .dazole or metabolic inhibitors , a FRAP which we
must attribute to some intravacuolar processes.
We further investigated the nocodazole-treated
cells and found that their fractional FRAP was the
same at 178C and 378C. These results indicate that
the residual FRAP in nocodazole- or metabolic in-
.hibitors -treated cells comes from a reversal of the
photochemical bleaching of Tf-LRSC as will be dis-
cussed later in this work.
3.7. FRAP of the intracellular transport of Tf-LRSC
endocytosed in A431 cells
Coming back to non-treated cells, we concluded
that two independent processes contributed to their
FRAP, namely an active intracellular transport of the
organelles containing Tf-LRSC and an intravacuolar
process of Tf-LRSC molecules. This last process was
very probably a spontaneous reactivation of the
bleached marker molecules. The intravacuolar pro-
cess was the only one which contributed to the FRAP
of cells treated by nocodazole. We approximated the
FRAP of nocodazole-treated cells by an exponential
function, the parameters of which are given in Table
2. The time constant is equal to 3.5 s, a much shorter
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value than that of the time constant of the transport
 .process see below . We obtained the fractional FRAP
of the intracellular transport of Tf-LRSC by subtract-
ing the fractional FRAP measured in nocodazole-
treated cells from the fractional FRAP of the cells
surrounded by DME without nocodazole see the
w x.companion paper 1 . The resulting curve is drawn in
Fig. 6.
w xAs discussed in the companion paper 1 and later
in this paper, we assumed that the active transport of
Tf-LRSC proceeded from a mechanism involving
carrier vesicles budding from stationary vacuoles,
saltating rapidly and finally fusing with other vac-
uoles.
 .We then fitted the function defined by Eq. 29 of
w xthe companion paper 1 to the experimental FRAP of
transport, and determined the values of L and t s1 1
1rh given in Table 2.1
3.8. FRAP of Tf-LRSC labelled A431 cells post-in-
cubated in DME containing AlF y4
In order to obtain more information on the origin
of the FRAP of Tf-LRSC internalized in A431 cells,
Table 2
Tf-LRSC internalized in A431 cells: parameters of the exponen-
tial function fitted to the experimental fractional FRAP of the
transport of Tf-LRSC and of the spontaneous reactivation of the
bleached markers
y1 y2 .  .Surrounding medium t s L t s mm1 1 f
a a .DME 54 a 0.64 0.15
y a a .DMEqAlF 104 a 0.64 0.074
a a .DMEqBFA 42 a 0.65 0.19
b .DMEqnocodazole 3.5 b 0.11 –
 .   ..The fitted function is y t s L 1yexp y tr t obtained in the1 1
w xcompanion paper 1 for the active transport of the marker by
  . w x.vesicles between stationary vacuoles Eq. 29 of this paper 1 .
The compositions of the surrounding media are given in Table 1.
t , time constant of the exponential function. L , fraction of the1 1
transported fluorescencea, or of the reactivatable fluorescenceb.
t , number of vesicles which fuse during 1 s with 1 mm2 off
vacuole surface, assuming that the vesicle is spherical with a
 .diameter of 0.2 mm and computed by applying Eq. 9 of the
w xcompanion paper 1 .
aFractional FRAP of transport of Tf-LRSC.
bFractional FRAP of the spontaneous reactivation of bleached
molecules.
Fig. 6. Fractional FRAP of the active transport of Tf-LRSC
internalized in A431 cells. The fluctuating curves 1, 2, 3 were
obtained by subtracting the curve 4 from the curves 1, 2, 3 of
Fig. 5, respectively. The smooth curves represents the function
 .   .. y t s L 1yexp y t r t derived in a companion paper Eq.1 1
 . w x.29 of 1 , the fitted parameters L and t having the values1 1
given in Table 2 of the present paper.
 ywe examined the effect of two compounds AlF and4
.BFA known to modify the fission–fusion processes
of membranous organelles.
A series of 121 single FRAP measurements was
performed on individual labelled cells post-incubated
with DME containing 100 mM AlCl and 5 mM3
NaF. It has been shown that aluminum fluoride
molecules of various stoichiometry were formed in
this mixture and that the most biologically active of
y w xthem was probably AlF 21 .4
The sum of these individual FRAP measurements
corrected for cell autofluorescence is drawn in Fig. 4,
and the corresponding fractional FRAP is given in
Fig. 5 where both curves can be compared with the
FRAP sum curves of non-treated cells. One can see
that the rate of fluorescence recovery decreases when
the cells have been treated by AlFy. When labelled4
cells were post-incubated with 1 mM of deferroxam-
ine or 5 mM of NaF plus 1 mM of deferroxamine, the
FRAP was identical to that of non-treated cells data
. 3qnot shown . These experiments showed that Al
ions were necessary, and NaF alone not sufficient, to
induce the change in FRAP. Deferroxamine chelates
3q w xany trace of Al 46 which might be present as an
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impurity in the different reagents or might have been
w xextracted by NaF from the glassware 47 .
Finally we measured the FRAP of A431 cells
post-incubated with DME containing 100 mM AlCl3
plus 5 mM NaF, and then post-incubated a second
time in the same medium in which was added 3 mM
of nocodazole. The fractional FRAP of these cells
was identical to the fractional FRAP of cells submit-
ted to a single post-incubation in DME containing 3
mM of nocodazole alone. Consequently, we took the
sum of both fractional FRAP curves obtained on cells
treated with nocodazole in presence and in absence
y. w xof AlF as the reference curve y 1 . This curve4 No
was represented in Fig. 3 and was used for computing
the fractional FRAP of transport in cells surrounded
 .by DME according to Eq. 28 of the companion
w xpaper 1 ; this fractional FRAP was drawn in Fig. 6.
The same curve y was used to determine theNo
 .FRAP drawn in the same figure of transport in
y  .AlF -treated cells. The function defined by Eq. 294
w xof the companion paper 1 was fitted to this frac-
tional FRAP of transport to provide the parameters of
the fission–fusion process given in Table 2.
3.9. FRAP of Tf-LRSC labelled A431 cells post-in-
cubated in Brefeldin A
In a last series of experiments, Tf-LRSC labelled
and non-labelled A431 cells were post-incubated in
 .DME containing 7 mgrml of Brefeldin A BFA . We
measured the FRAP of 149 of these labelled cells.
The sum of these FRAP curves, corrected for cell
autofluorescence, is given in Fig. 4, and the corre-
sponding fractional FRAP in Fig. 5.
As seen above, the morphology and the cytoplas-
mic distribution of the fluorescent vacuoles of la-
belled cells treated with BFA and then with nocoda-
zole, were the same as those of cells treated with
nocodazole alone or of cells treated with AlFy and4
nocodazole. We then obtained the FRAP of the trans-
port process of BFA-treated cells by applying the
 .subtraction defined in Eq. 28 of the companion
w x  .paper 1 in which y t was the experimental func-No
tion determined above. The fractional FRAP of trans-
port resulting from this subtraction is drawn in Fig. 6.
 .The exponential function expressed by Eq. 29 of the
w xcompanion paper 1 was fitted to the experimental
fractional FRAP. The values of both parameters of
the fission–fusion process of the endosomal system
in BFA-treated cells were then obtained see Table
.2 .
4. Discussion
In eukaryotic cells, carrier vesicles transfer various
kinds of macromolecules between stationary or-
w xganelles 22–25 . Our aim in this work was to deter-
mine how the FRAP technique could provide infor-
mation on the dynamics of the intracellular trans-
ports. We chose to investigate the late endocytic
 .compartment of transferrin in A431 cells LCT ,
defined in both introductions of a companion paper
w x1 and the present paper. We took the conjugate of
transferrin with Lissamine Rhodamine Sulfochoride
 .Tf-LRSC as a fluorescent marker of the LCT com-
partment.
With the microfluorimetry technique, we found
that Tf-LRSC was internalized by transferrin recep-
w xtors, as already reported by others 4–6 .
After 1 h of incubation in the culture medium
 .DME containing Tf-LRSC, A431 cells rapidly exo-
cytosed a fraction of the fluorescent markers, while
they were very slowly eliminating another fraction of
them. By measuring the exocytosis kinetics of trans-
ferrin labelled with radioactive iodine, other authors
observed that a fraction of the endocytosed marker
w xslowly recycled itself 15,17 . By confocal mi-
croscopy, we found that the slowly recycling Tf-
LRSC fraction was included in vacuoles dispersed
throughout the cytoplasm of A431 cells, and some-
times aggregated preferentially in the perinuclear area.
Similar microscopy images had been previously seen
in various cell lines having endocytosed either fluo-
rescein-labelled transferrin or non-labelled transferrin
w xrevealed by immunofluorescence 26,27 . The vac-
uoles accumulating Tf-LRSC during the slow recy-
cling process of endocytosis were identified as form-
ing the late endocytic compartment of transferrin
 . w xLCT 28,29 .
Ultrastructural studies of A431 cells, labelled with
Tf-LRSC or ATR-gold complexes, showed that the
w xLCT compartment was made of MVB 30,31 .
The FRAP experiments described in the present
work precisely concerned Tf-LRSC internalized in
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the LCT of the A431 cells. These conditions were
realized by incubating the cells during 1 h in DME
containing Tf-LRSC. The labelled cells were then
 .post-incubated chased during 1 h in DME without
any marker, and the FRAP measurements were per-
formed in the post-incubation medium.
In the following discussion, we call FRAP the sum
of 100 to 200 FRAP measurements performed on
single labelled cells identically prepared, this sum
being corrected for cell autofluorescence.
We found that the FRAP of cells surrounded by
DME alone was relatively large. When we added
nocodazole or metabolic inhibitors in the chase and
measurement media, the FRAP was considerably re-
duced, which showed that the FRAP of Tf-LRSC in
non-treated cells contained an important contribution
of an active intracellular transport. There remained,
however, a residual FRAP in nocodazole- or
metabolic inhibitors-treated cells, which must be as-
cribed to some intravacuolar processes. These in-
travacuolar processes may include the following pos-
sibilities: the marker diffusion of translation and rota-
w xtion 32,33 , the spontaneous reversal of the photo-
w xchemical reaction 33–35 or some chemical ex-
w xchange reactions 36 . We found that the FRAP of
nocodazole-treated cells was independent from tem-
perature. Consequently the FRAP could not be at-
tributed to any of the above mentioned mechanism
except the spontaneous reactivation of the bleached
molecules, generally called a reversible photochemi-
cal reaction. Other authors measured the FRAP of
fluorescent protein conjugates bound to the cytoplas-
mic side of the plasmic membrane or adsorbed on
w xglass in a deoxygenated environment 34,35 . They
found this type of reactivation of bleached molecules
with a time constant of the order of a second. We
found that the time constant of the FRAP measured
in nocodazole-treated cells was equal to 3.5 s.
In the FRAP of cells surrounded by DME without
nocodazole, we distinguished two contributions: one
proceeding from an intracellular transport and the
other proceeding from a spontaneous reactivation of
the bleached marker, reactivation which brought about
the FRAP of nocodazole-treated cells. In a compan-
w xion paper 1 we established that the fractional FRAP
due to the contribution of two simultaneous processes
was the sum of the fractional FRAP of each process
occurring separately, provided that the values of the
characteristic time of these processes were very dif-
w xferent from each other 1 . By subtracting the frac-
tional FRAP of nocodazole-treated cells from the
fractional FRAP of the non-treated cells, we obtained
a curve to which we could fit an exponential function
of time constant equal to 52 s. This value was
definitely larger than the time constant value of the
FRAP of nocodazole-treated cells. Consequently, the
curve derived by this subtraction represented the
fractional FRAP of the intracellular transport process
w xof Tf-LRSC 1 .
Our interpretation of the FRAP of transport was
grounded on the VM observations of ATR-gold in
A431 cells. We ascribed the intracellular Tf-LRSC
active transport to a mechanism involving succes-
sively the following three steps: budding of small
 .vesicles from stationary vacuoles MVB , rapid salta-
tions of these vesicles along microtubules, and fusion
with other distant stationary vacuoles. Assuming that
the membranous exchange between vesicles and vac-
uoles was in a steady state see the companion paper
w x.1 , we ascertained that the formation rate of vesicles
by fission was equal to the rate of their fusion with
vacuoles. We assumed then that the travelling veloc-
ity of the vesicles was high compared to the rate of
vesicles fusion, and we showed that the mathematical
expression of the FRAP of transport was an exponen-
tial function with a time constant inversely propor-
tional to the rate of the vesicle fusion with the
w xvacuoles 1 . According to the VM observations, the
y1 w xaverage velocity of the vesicles is about 1 mm s 2
so that the average length of time spent by the
 .vesicles to cross the laser beam of radius 1.8 mm is
1.8 s, a negligible time compared to the experimental
value of the characteristic time of the FRAP of
 .Tf-LRSC transport measured here ;52 s . This
short time of 1.8 s justifies our considering the FRAP
of transport as controlled by the fission–fusion pro-
cesses. Knowing that the vesicular diameter is equal
w x  .to 0.2 mm 2 , we applied the Eq. 9 of the compan-
w xion paper 1 and we calculated the number of vesi-
cles which fused per unit of vacuole surface; we
found it equal to 0.15 mm-2 s-1. According to the EM
observations, the average diameter of a MVB vacuole
w x  .is equal to 1.5 mm 30,31 . By applying Eq. 7 of the
w xcompanion paper 1 , we found that there were 60
vesicles which fused with one vacuole during one
minute.
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Papers reporting measurements of the rate of
vesicular fusion with stationary organelles in vivo,
are scarce. Using quantitative fluorescence mi-
 . w xcroscopy, Dunn et al. 1989 37 measured the fluo-
rescence increase with time of a single sorting endo-
some in CHO cells having internalized the Rho-
damine conjugate of transferrin. These authors found
that there were more than four endocytic vesicles
which fused per minute with one stationary endo-
some. According to our FRAP measurements, the
number of vesicles which fused per minute with one
MVB of A431 cells was then 15-times higher than
 . w xthe lower limit determined by Dunn et al. 1989 37 .
We must, however, observe that the cell lines and the
endocytic compartments involved in both works, ours
and theirs, are different.
When AlFy was present in the medium surround-4
ing the labelled A431 cells, the time constant of the
FRAP of Tf-LRSC transport was multiplied by two,
relatively to its value for non-treated cells. If the
change of the spatial distribution of vacuoles, induced
by AlFy in the cell, influenced the value of the time4
constant of the transport FRAP, this change should
also significantly modify the value of the apparent
fraction of the transported Tf-LRSC, L . Since this1
was not the case, we concluded that AlFy caused a4
50% decrease in t , the number of vesicles whichf
fused with the vacuoles in one second per unit of
vacuole surface. AlFy specifically replaces GTP in4
w xthe nucleotide site of heterotrimeric G-proteins 21
which intervene in the regulation of fission–fusion
processes, during the transfer of components between
organelles of the endocytosis and exocytosis path-
w x yways 22,37 . AlF inhibits the transport between4
w xorganelles in vivo and in vitro 38–40 . Our results
agree with this general effect of AlFy.4
We found that BFA did not modify the apparent
fraction L of Tf-LRSC transported in A431 cells.1
On the other hand, the time constant of the BFA-
treated cells was 20% lower than the time constant of
the non-treated cells. This result must then be as-
cribed to an increase in t , by 20%. BFA is af
macrocyclic lactone synthetized by a variety of fungi.
This compound does not significantly modify the
intracellular homotypic membranous traffic, implying
fusion between like organelles as for example fusion
between endosomes or between elements of the endo-
.plasmic reticulum . On the other hand, BFA inhibits
the membranous heterotypic traffic involving trans-
w xport between different homotypic organelles 7,25 .
Our FRAP measurements, therefore, indicate that the
fission–fusion processes between vesicles and sta-
tionary vacuoles are homotypic, which we expected.
With fluorescence videomicroscopy, Hopkins et al.
 .1990 observed Hep2 carcinoma cells having previ-
ously been incubated for more than one hour in a
culture medium containing transferrin conjugated to
w xTexas Red 41 . In these cells, they saw fluorescent
 .MVB vacuoles moving very slowly by saltation,
which suggests that saltation of MVB might also
contribute to the FRAP of Tf-LRSC internalized in
A431 cells. On the other hand, VM of A431 cells let
appear that the velocity of endosomes containing
ATR-gold and moving by saltations varied according
to the size of these organelles: the larger they were,
w xthe slower they moved 2 . Therefore, it may be
expected that the velocity of the large tubular endo-
somes induced by BFA should be considerably re-
duced if not null. On the contrary, as above men-
tioned, our FRAP measurements indicated a small
increase in the transport rate when the A431 cells
were treated by BFA. We concluded that the salta-
tions of MVB cannot play an important role for the
transport of transferrin in the LCT of A431 cells.
The present state of our experimental studies does
not allow us to give an exact meaning of the fraction
L of the transported Tf-LRSC. We may, however,1
remark that we assumed Tf-LRSC to be bound to the
limiting membrane of the vacuoles. The EM studies
of Tf-HRP suggest that some Tf-LRSC is situated in
w xthe vacuole lumen 30,31 . The rate of transport of
the Tf-LRSC molecules is expected to be different
according as they are situated in the limiting mem-
brane or in the lumen of the vacuoles. This hetero-
geneity of rate might explain why only a fraction of
the marker appeared to be transported.
On the other hand, when A431 cells were incu-
bated for 60 min with ATR-gold or Tf-HRP and then
transferred 60 min in a medium without ligand, the
observations of these cells by EM showed that only a
part of the ligands was located in MVB, the rest
w xbeing situated in lysosome-like vacuoles 30 . There-
fore one may identify the Tf-LRSC fraction non-
transported within the A431 cells to the fraction of
ligands included in lysosome-like vacuoles.
By analysing the fluorescent microscopy images of
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CHO and Hep2 cells, Maxfield et al. showed that the
complex of FITC-transferrin with the Tf-Receptor
was first internalized in sorting endosomes and then
in the recycling compartment from which the ligand
is exocytosed into the extracellular medium
w x w x37,48,49 . In a recent paper 50 , Ghosh and Max-
field found that the ligand is partially transported
backwards from the recycling compartment to the
sorting endosomes, this mechanism producing a delay
in exocytosis. The LCT of A431 cells may be identi-
cal to the recycling compartment, and a part of the
Tf-LRSC transport measured by us may be ascribed
to the non-vectorial exchange between the sorting
endosomes and the recycling compartment. Accord-
ing to Ghosh and Maxfield, this non-vectorial ex-
change may be used by the cell in order to store
proteins of sorting endosomes into the recycling com-
partment, allowing the sorting endosomes to mature
w xinto prelysosomal endosomes 50 .
In conclusion, our FRAP measurements show that
there is an active intracellular transport of Tf-LRSC
in A431 cells, a long time after the ligand entered
these cells. This transport can be satisfactorily de-
scribed by a mechanism involving three steps: small
carrier vesicles saltating rapidly along the micro-
tubules, then budding from and fusing with stationary
endosomes. This description corresponds to the VM
observations of ATR-gold complexes internalized in
w xcells of the same line 2 . The number of vesicles
which fuse per second and per unit of vacuole surface
can be deduced from the analysis of the FRAP data.
This parameter cannot be obtained easily in vivo by
other techniques currently used in cell studies. AlFy4
modifies the FRAP of endocytosed Tf-LRSC in a
way which indicates that the transport of Tf in the
late endocytosis compartment of A431 cells is proba-
bly controlled by an heterotrimeric G-protein. The
action of BFA on the FRAP shows that the transport
is homotypic, as expected.
The present work suggests that FRAP could be an
interesting non-invasive technique to get information
on membranous transport of organelle components
w xwithin eukaryotic living cells 41–44 . It may be
expected that the full efficiency of the technique
would be obtained in conjunction with video mi-
croscopy and pharmacological agents tested for their
effect on vesicular movements along microtubules
w x45 .
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